SGC in the News

Explore our news articles and stay connected with the SGC.

Read about the latest breakthroughs, awards and ongoing work from the SGC. Discover how our work is making a global impact and driving forward the field of drug discovery. Interested in getting first the latest news from SGC?

 

Small molecule compound used to probe into the role of Mps1

The successful segregation of chromosomes in mitosis requires the timely coordination of cell cycle events to ensure the bipo¬lar attachment of sister chromatids via their kinetochores to the mitotic spindle before the initiation of anaphase. Deregulation of this process or uncoupling of its…

Opening the gates for a new therapeutic opportunity in the fight against apicomplexan parasites

Apicomplexan parasites are a diverse group of protozoan parasites, several of which cause important human and animal diseases, such as malaria, cryptosporidiosis and toxoplasmosis. Many of these diseases are endemic in developing countries, which are impacted by the lack of cost-efficient…

New drug leads to treat toxoplasmosis unveiled by collaboration between Washington University, UCSF and the SGC

Toxoplasmosis is a parasitic disease caused by the apicomplexan protozoa Toxoplasma gondii and can pose a significant threat to immunocompromised individuals, e.g. those undergoing organ transplantation or chemotherapy and HIV/AIDS patients, who cannot fight back the infection and are thus…

Categories